These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34118373)

  • 61. Hybrid effectiveness-implementation trial of guided relaxation and acupuncture for chronic sickle cell disease pain (GRACE): A protocol.
    Doorenbos AZ; Schlaeger JM; deMartelly VA; Burke LA; Boyd AD; Knisely MR; Leigh JW; Li H; Mandernach MW; Molokie RE; Patil CL; Steffen AD; Shah N; Ezenwa MO
    Contemp Clin Trials Commun; 2023 Apr; 32():101076. PubMed ID: 36852100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Causes of hospitalization in sickle cell diseased children in western region of Saudi Arabia. A single center study.
    Abd Elmoneim AA; Al Hawsawi ZM; Mahmoud BZ; Bukhari AA; Almulla AA; Sonbol AM; Makhdoum AM
    Saudi Med J; 2019 Apr; 40(4):401-404. PubMed ID: 30957136
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Widespread Pain Among Youth With Sickle Cell Disease Hospitalized With Vasoocclusive Pain: A Different Clinical Phenotype?
    Zempsky WT; Wakefield EO; Santanelli JP; New T; Smith-Whitley K; Casella JF; Palermo TM
    Clin J Pain; 2017 Apr; 33(4):335-339. PubMed ID: 27322398
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospital.
    Vijenthira A; Stinson J; Friedman J; Palozzi L; Taddio A; Scolnik D; Victor C; Kirby-Allen M; Campbell F
    Pain Res Manag; 2012; 17(4):291-6. PubMed ID: 22891195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
    Taylor LE; Stotts NA; Humphreys J; Treadwell MJ; Miaskowski C
    J Pain Symptom Manage; 2010 Sep; 40(3):416-35. PubMed ID: 20656451
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study.
    Johnson A; Yang F; Gollarahalli S; Banerjee T; Abrams D; Jonassaint J; Jonassaint C; Shah N
    JMIR Mhealth Uhealth; 2019 Dec; 7(12):e13671. PubMed ID: 31789599
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of opioid use in sickle cell disease.
    Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of fetal hemoglobin level with frequency of acute pain episodes in sickle cell disease (HbS-only phenotype) patients.
    Jit BP; Mohanty PK; Purohit P; Das K; Patel S; Meher S; Mohanty JR; Sinha S; Behera RK; Das P
    Blood Cells Mol Dis; 2019 Mar; 75():30-34. PubMed ID: 30597429
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Multiyear Cross-sectional Study of Guideline Adherence for the Timeliness of Opioid Administration in Children With Sickle Cell Pain Crisis.
    Brousseau DC; Alpern ER; Chamberlain JM; Ellison AM; Bajaj L; Cohen DM; Hariharan S; Cook LJ; Harding M; Panepinto J;
    Ann Emerg Med; 2020 Sep; 76(3S):S6-S11. PubMed ID: 32928464
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluating Acupuncture and Standard carE for pregnant women with Back pain (EASE Back): a feasibility study and pilot randomised trial.
    Foster NE; Bishop A; Bartlam B; Ogollah R; Barlas P; Holden M; Ismail K; Jowett S; Kettle C; Kigozi J; Lewis M; Lloyd A; Waterfield J; Young J
    Health Technol Assess; 2016 Apr; 20(33):1-236. PubMed ID: 27133814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.
    Calhoun G; Wang L; Almeida LE; Kenyon N; Afsar N; Nouraie M; Finkel JC; Quezado ZM
    Eur J Pharmacol; 2015 May; 754():125-33. PubMed ID: 25724786
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Daily changes in pain, mood and physical function in children hospitalized for sickle cell disease pain.
    Zempsky WT; Palermo TM; Corsi JM; Lewandowski AS; Zhou C; Casella JF
    Pain Res Manag; 2013; 18(1):33-8. PubMed ID: 23457684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Navigating Ethical Challenges for Pediatric Sickle Cell Pain Management in the Context of the Opioid Epidemic.
    Mulchan SS; Wakefield EO; Martin SR; Ayr-Volta L; Krenicki K; Zempsky WT
    Clin J Pain; 2021 Nov; 38(2):88-94. PubMed ID: 34803155
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease.
    Beverung LM; Varni JW; Panepinto JA
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):128-33. PubMed ID: 24942019
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Management of an acute painful sickle cell episode in hospital: summary of NICE guidance.
    Gillis VL; Senthinathan A; Dzingina M; Chamberlain K; Banks E; Baker MR; Longson D;
    BMJ; 2012 Jun; 344():e4063. PubMed ID: 22740566
    [No Abstract]   [Full Text] [Related]  

  • 77. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acceptability and Feasibility of a Mindfulness-Based Intervention for Pain Catastrophizing among Persons with Sickle Cell Disease.
    Simmons LA; Williams H; Silva S; Keefe F; Tanabe P
    Pain Manag Nurs; 2019 Jun; 20(3):261-269. PubMed ID: 31085097
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A telephonic mindfulness-based intervention for persons with sickle cell disease: study protocol for a randomized controlled trial.
    Williams H; Silva S; Simmons LA; Tanabe P
    Trials; 2017 May; 18(1):218. PubMed ID: 28506281
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease.
    Jhun E; He Y; Yao Y; Molokie RE; Wilkie DJ; Wang ZJ
    Anesth Analg; 2014 Nov; 119(5):1201-7. PubMed ID: 25102390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.